In comparison, in the two resistant luminal breast cancer cell lines BT474 and MCF7, treatment with an equitoxic dose of V158411 resulted in a decrease in Chk1 protein levels but not a subsequent increase in H2AX phosphorylation (Figure 3B). The gene discussed is CHEK1; the disease is breast carcinoma.